Our reputation as gene synthesis specialists is consistently emphasized as our competitors fail to deliver large (5kb to 25kb+) and complex genes, whereas we have an over 95% completion rate on even the most challenging of sequences. Any company which relies purely on silicon well-based platforms is limited to the construction of small and simple genes, thereby limiting their ability to work on a significant portion (up to 50%) of gene projects.